GenScript is a company based in the USA that operates within the Corporate Services industry, specifically focusing on the biotech and pharmaceutical sectors. With a workforce of approximately 5,568 employees and reported revenues of $594 million, GenScript is engaged in providing a range of corporate services that support research and development activities. The company emphasizes its expertise in areas such as biotechnology and pharmaceuticals, which is reflected in its published materials. One notable document is the "CRISPR Regulatory White Paper," which discusses regulatory considerations surrounding CRISPR technology, indicating GenScript's involvement in cutting-edge research and its commitment to addressing compliance and regulatory challenges in the biotech field. This white paper contributes to the broader discourse on gene editing technologies, showcasing GenScript's role in advancing scientific understanding and application of CRISPR. Overall, GenScript's focus on research and corporate services positions it as a significant player in the biotech landscape, particularly in relation to innovative technologies and regulatory frameworks.